Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenuit Group Regulatory News (GEN)

Share Price Information for Genuit Group (GEN)

Share Price is delayed by 15 minutes
Get Live Data
254.00    2.00 (0.79%)
Bid:
254.00
Ask:
255.40
Spread: 1.40 (0.551%)
Market Cap: £640.05m
GEN Live PriceLast checked at - London Stock Exchange

Intraday Genuit Group Share Chart

Trading Update

25 Oct 2022 07:00

RNS Number : 9471D
Genuit Group PLC
25 October 2022
Β 

Genuit Group plc

Trading Update __________________________________________________________________________________

Β 

25 October 2022

Β 

Genuit Group plc ("Genuit", the "Company" or the "Group"), a leading provider of sustainable water, climate and ventilation products for the built environment, today issues an update on trading for the nine months ended 30 September 2022.

Β 

Group revenue for the nine months ended 30 September 2022 was Β£472 million (2021: Β£451 million) representing growth of 4.7% on a strong comparative period. On a like-for-like basis, Group revenue growth was 3.0%.

Β 

Β· For the nine months, Residential sales were Β£297 million up 6.2% (4.8% on a like-for-like basis) on the prior year and Commercial & Infrastructure sales were Β£176 million up 2.3% (0.4% on a like-for-like basis) over the same period.

Β 

Β· Against a backdrop of increased macro-economic and political uncertainty, the Group has experienced tougher trading conditions over recent weeks and has not seen the normal seasonal uplift in volumes in the latter part of Q3. This has impacted most parts of the business, and in particular RMI, although the areas that are driven by the need for energy efficiency are trading well.

Β 

Β· The Group continues to proactively counter ongoing cost inflation through robust price leadership and a successful September price increase has been implemented in parts of our business to deal with these continued pressures. Measures, including a planned restructuring, are also actively being taken to improve the efficiency of our operations and these will deliver approximately Β£8 million of savings on an annualised basis.Β 

Β 

Β· Supply chain issues persist and the constraint in the supplyΒ of semiconductors and printed circuit boards in the upstream boiler market remain, inhibiting customer demand. We remain vigilant that further challenges to our supply chain such as the constraint in the supply of blowers to our Climate & Ventilation division are proactively mitigated to the greatest possible extent.

Β· The Group remains highly cash generative and net debt has reduced since the half year. We anticipate that capital expenditure for the full year will be approximately Β£40 million and the Group expects to report pre-IFRS16 net debt to EBITDA of circa 1.2x at the year end, reduced from 1.5x at 30 June 2022.

Β 

Β· As a consequence of the uncertainty impacting trading in the latter part of Q3, the Board now expects profit for the year to be at the lower end of analyst expectations*.

Β 

Joe Vorih, Chief Executive Officer, commented:

"The overall trading environment remains challenging, and we are seeing some slowing in line with pressures on the sector. Β RMI is particularly impacted, though some bright spots remain, including conversion to renewable heating and improvement to existing heating system efficiency.Β Β The Group is well positioned to weather this uncertainty, with variable manufacturing capacity and we have already undertaken significant self-help measures with planned improvements to our cost structure.Β Β  The medium- and long-term fundamentals of the Group are strong, as legislative growth drivers, customer commitments to Net Zero, and the climate-driven need for low-carbon heating solutions, improved building ventilation, and resilient stormwater management all play to Genuit's strengths."

Β 

Capital Markets Day

The Group will hold an in-person Capital Markets Day for investors and analysts on Thursday 10 November 2022 at the Group's Adey business in Gloucestershire.

Β 

Full Year Results

Full year results for the year ending 31 December 2022 will be announced on 14 March 2023.

Β 

* Genuit compiled analyst consensus forecast range for 2022 shows EBIT of Β£96.8 - Β£109.0 million.

Β 

Enquiries:

Β 

Genuit +44 (0) 113 831 5315

Β 

Joe Vorih, Chief Executive Officer

Paul James, Chief Financial Officer

Β 

Brunswick +44 (0) 2074 045 959

Β 

Nina Coad

Tom Piggot

Β 

Notes to Editors:

Genuit Group plc ("Genuit" or the "Group"), a leading provider of sustainable water and climate management solutions for the built environment, is the largest manufacturer in the UK, and among the ten largest manufacturers in Europe, of piping systems for the residential, commercial, civils and infrastructure sectors by revenue. It is also a leading designer and manufacturer of energy efficient ventilation systems in the UK.

The Group operates from 30 facilities in total and manufactures the UK's widest range of solutions for heating, plumbing, drainage and ventilation. The Group primarily targets the UK and European building and construction markets with a presence in Italy, the Netherlands and the Middle East and sales to specific niches in the rest of the world.

Genuit Group plc changed its corporate name from Polypipe Group plc on 6 April 2021. The Group was established in 1980 and has been listed on the London Stock Exchange since 2014.

Β 

END

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTMIBMTMTMTTIT
Date   Source Headline
4th Jun 20263:05 pmRNSHolding(s) in Company
2nd Jun 20261:15 pmRNSDirector/PDMR Shareholding
29th May 20262:39 pmRNSTotal Voting Rights
29th May 20262:23 pmRNSHolding(s) in Company
29th May 20261:59 pmRNSDirector/PDMR Shareholding
28th May 20262:24 pmRNSHolding(s) in Company
27th May 202610:07 amRNSDirector/PDMR Shareholding
26th May 20263:49 pmRNSHolding(s) in Company
22nd May 20263:01 pmRNSResult of AGM
22nd May 20267:00 amRNSTrading Update
5th May 20269:00 amRNSDirector/PDMR Shareholding
1st May 20264:12 pmRNSDirector/PDMR Shareholding
30th Apr 20264:26 pmRNSAdmission to Trading
30th Apr 20264:17 pmRNSTotal Voting Rights
30th Apr 20264:06 pmRNSDirector/PDMR Shareholding
27th Apr 20264:20 pmRNSHolding(s) in Company
14th Apr 20264:32 pmRNSDirector/PDMR Shareholding
14th Apr 202610:11 amRNSNotice of AGM
10th Apr 20261:34 pmRNSBlock Listing Application
7th Apr 20269:58 amRNSHolding(s) in Company
1st Apr 202610:00 amRNSDirector/PDMR Shareholding
31st Mar 20266:01 pmRNSTotal Voting Rights
23rd Mar 20263:25 pmRNSHolding(s) in Company
20th Mar 20261:43 pmRNSDirector/PDMR Shareholding
13th Mar 20269:41 amRNSHolding(s) in Company
13th Mar 20269:41 amRNSHolding(s) in Company
11th Mar 20262:12 pmRNSFull-Year 2025 Results Investor Q&A
10th Mar 20267:00 amRNSFinal Results
6th Mar 202611:35 amRNSHolding(s) in Company
5th Mar 20262:46 pmRNSHolding(s) in Company
5th Mar 20262:41 pmRNSHolding(s) in Company
4th Mar 20262:40 pmRNSHolding(s) in Company
3rd Mar 20263:51 pmRNSHolding(s) in Company
2nd Mar 20265:25 pmRNSHolding(s) in Company
27th Feb 20263:18 pmRNSTotal Voting Rights
30th Jan 20266:00 pmRNSTotal Voting Rights
29th Jan 202610:17 amRNSHolding(s) in Company
29th Jan 202610:15 amRNSHolding(s) in Company
29th Jan 202610:06 amRNSHolding(s) in Company
12th Jan 20265:41 pmRNSHolding(s) in Company
31st Dec 202510:00 amRNSTotal Voting Rights
31st Dec 202510:00 amRNSTotal Voting Rights
23rd Dec 20259:08 amRNSHolding(s) in Company
23rd Dec 20259:08 amRNSHolding(s) in Company
23rd Dec 20259:06 amRNSHolding(s) in Company
23rd Dec 20259:06 amRNSHolding(s) in Company
16th Dec 20252:03 pmRNSHolding(s) in Company
16th Dec 20252:01 pmRNSHolding(s) in Company
12th Dec 20253:41 pmRNSDirector/PDMR Shareholding
10th Dec 20254:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.